
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
These dynamics can rattle even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. That said, here is one mid-cap stock with huge upside potential and two best left ignored.
Two Mid-Cap Stocks to Sell:
Dover (DOV)
Market Cap: $25.43 billion
A company that manufactured critical equipment for the United States military during World War II, Dover (NYSE: DOV) manufactures engineered components and specialized equipment for numerous industries.
Why Do We Think Twice About DOV?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Earnings growth underperformed the sector average over the last two years as its EPS grew by just 5.6% annually
- Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
At $186.52 per share, Dover trades at 16.9x forward P/E. If you’re considering DOV for your portfolio, see our FREE research report to learn more.
DaVita (DVA)
Market Cap: $11.43 billion
With over 2,600 dialysis centers across the United States and a presence in 13 countries, DaVita (NYSE: DVA) operates a network of dialysis centers providing treatment and care for patients with chronic kidney disease and end-stage kidney disease.
Why Are We Wary of DVA?
- Flat treatments over the past two years imply it may need to invest in improvements to get back on track
- Estimated sales growth of 2% for the next 12 months implies demand will slow from its two-year trend
- Static adjusted operating margin over the last two years shows it couldn’t become more efficient
DaVita is trading at $179.10 per share, or 11.3x forward P/E. Dive into our free research report to see why there are better opportunities than DVA.
One Mid-Cap Stock to Buy:
Instacart (CART)
Market Cap: $11.06 billion
Powering more than one billion grocery orders since its founding, Instacart (NASDAQ: CART) is an online grocery shopping and delivery platform that partners with retailers to help customers shop from local stores through its app or website.
Why Will CART Beat the Market?
- Prominent and differentiated platform results in a top-tier gross margin of 73.6%
- Excellent EBITDA margin of 28.9% highlights the efficiency of its business model, and its profits increased over the last few years as it scaled
- CART is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders, and its improved cash conversion implies it’s becoming a less capital-intensive business
Instacart’s stock price of $47.40 implies a valuation ratio of 7.7x forward EV/EBITDA. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.